Sinclair Pharma plc Acquires Flammazine, Flammacerium from Solvay Pharmaceuticals, Inc. for EUR 17.5 Million; Gets New CEO

Bookmark and Share

Reuters -- Britain's Sinclair Pharma Plc said on Monday it would buy two burn creams with the proceeds of a share issue and its chief executive would retire as a replacement had been found.

Back to news